Theralase Technologies Inc. V.TLT

curious about the exchanges

[DJDawg]

Since we are in newsletter limbo, I had a question. What is the deal with exchanges. I know that TLT is on the venture exchange. I'm Canadian. That isn't a stigma to me. Just means company may be smaller and not up to paying larger listing fees.

How is this issue percieved outside of Canada. Does TLT immediately get a lower estimation by Americans because it is on a non-NASDAQ type exchange or OTCC? I could see that would be a long time drag on investor interest. Part of the reason I ask is that I see some American biotech startup with very preliminary lab data gettig huge cash IPO based on far weaker data than TLT. I almost imagine (in some parallel universe) that if they relocated to Boston and shopped their data around the venture investors, they would likely get the same IPO excitement as some of the other biotechs that have a way earlier and riskier path to the market.

So I guess, I'm just curious, does being on the OTCC or venture exchange likely keep a lot of investors from knowing about and hearing about TLT? Does it prevent them getting invites to all the investor info meetings? I'm sure the master plan would be to one day go to NASDAQ but for the time being are most of the people here Canadian. There are some posters who obviously Americans from their tone and style (we all know who I'm talking about) but are most of us Canadian...or are Canadian in the minority.

Just asking because nothing else going on right now :)

[Bigkahuna57]

Hi DJ, IMO, yes.  NASDAQ has more exposure, however many investment funds have policies that prevent them from investing below $4-$5 sp.  My other investment is from CA too. TMDI.  But they also have a US R&D Company in NC.  They were on this exchange, and went through a very nasty conversion/uplist to the NASDAQ.  Went through a Reverse Split at 30:1, and killed the

[Infinity]

Agree with you Big K57,  a reverse split at this stage would completely disasterous to the selling price.  Had a small investment in a canadian canabis company  FSD Pharma  ticker HUGE that went through a reverse split so that they can uplist to the NASDAQ that resulted in substantial losses.  The selling price never recovered and ultimately the CEO who decided on the

[99942Apophis]

I see this conversation has returned to the subject of a reverse split more accurately called consolidation!  Share count at this moment for Theralase is 204 million which in my book are below average for any company at the point of providing proof of success. We should with strong positive emphasis on should see a rise in share price  at each news release demonstrating Complete Response

[StevenBirch]

There are two reasons not to worry about a reverse split, 1. there are catalysts in the near term that could move the price so they could finance at a higher price plus their association with LKSKI and 2. their largest shareholder Roger who continues to add to his position said at the AGM 2 years ago there would be no reverse split. I know conditions change but Roger was adamant about it. Having

[skys1]

At least 90% of the time a reverse split is caused by a need for funding. As I have said several times now with the recent additional relationships with two very well financed entities there won't be a need for another PP financing. Do you realise Li Ka Shing has already given away at least $3 billion to worthwhile medical causes? Secondly, the reason Shawn left was because he finally came to